Home › NDC Lookup › RxCUI directory › RxCUI 2467582

Lonafarnib 50 MG Oral Capsule — RxCUI 2467582

RxNorm drug concept · Semantic clinical drug
RxCUI 2467582 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2467582
Official nameLonafarnib 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lonafarnib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zokinvy is used for two very rare genetic conditions. The main one is Hutchinson-Gilford Progeria Syndrome — a severe premature-aging disease that mostly affects children. The medi...
  • What exactly is Zokinvy used for? I've never heard of progeria before.
  • Taking Zokinvy with food — specifically with the morning and evening meals — is really important because it helps reduce stomach side effects like vomiting and nausea. These are th...
  • Why does my child have to take this with food every single time?
📖 Read our full Lonafarnib guide →

🕸️ Concept Web — How Lonafarnib 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lonafarnib 50 MG Oral Capsule RxCUI 2467582

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lonafarnib 2467553
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zokinvy 2467583
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lonafarnib Oral Capsule 2467581
    • Lonafarnib Oral Product 2467579
    • Lonafarnib Pill 2467580
    • Lonafarnib Oral Capsule [Zokinvy] 2467585
    • Zokinvy Oral Product 2467586
    • Zokinvy Pill 2467587
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lonafarnib 50 MG SCDC · 2467578
  • Lonafarnib Oral Capsule SCDF · 2467581
  • Lonafarnib Oral Product SCDG · 2467579
  • Lonafarnib Pill SCDG · 2467580

Brand-Name Concepts

  • Lonafarnib 50 MG Oral Capsule [Zokinvy] SBD · 2467588
  • Lonafarnib 50 MG [Zokinvy] SBDC · 2467584
  • Lonafarnib Oral Capsule [Zokinvy] SBDF · 2467585
  • Zokinvy Oral Product SBDG · 2467586
  • Zokinvy Pill SBDG · 2467587
  • Zokinvy BN · 2467583

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2467582 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42358-0450-30 1 BOTTLE, PLASTIC in 1 CARTON (42358-450-30) / 30 CAPSULE i... Zokinvy Sentynl Therapeutics, Inc. 2025-07-02
42358-0475-30 1 BOTTLE, PLASTIC in 1 CARTON (42358-475-30) / 30 CAPSULE i... Zokinvy Sentynl Therapeutics, Inc. 2025-07-02
Observed labelers: Sentynl Therapeutics, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.